Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Sponsor
University Hospital Regensburg (Other)
Overall Status
Completed
CT.gov ID
NCT01610804
Collaborator
(none)
18
1
13
1.4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    18 participants
    Time Perspective:
    Prospective
    Official Title:
    Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology
    Study Start Date :
    Apr 1, 2011
    Actual Primary Completion Date :
    Nov 1, 2011
    Actual Study Completion Date :
    May 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    CSCR-Patients

    Patients suffering from Central Serous Chorioretinopathy

    Healthy Subjects

    Healthy subjects with (assumed) normal choroidal thickness

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 80 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Patients with initial diagnosis of CSCR and no treatment so far
      Exclusion Criteria:
      • Therapy (drugs/laser) due to CSCR

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University Hospital Regensburg Regensburg Bavaria Germany 93053

      Sponsors and Collaborators

      • University Hospital Regensburg

      Investigators

      • Study Chair: Maria A Gamulescu, PD Dr. med., University Hospital Regensburg

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      Caroline Brandl, MD, University Hospital Regensburg
      ClinicalTrials.gov Identifier:
      NCT01610804
      Other Study ID Numbers:
      • CSCR2011
      First Posted:
      Jun 4, 2012
      Last Update Posted:
      Jun 4, 2012
      Last Verified:
      May 1, 2012

      Study Results

      No Results Posted as of Jun 4, 2012